Displaying drugs 10926 - 10950 of 12697 in total
NCX 1015
NCX 1015 is nitric oxide-releasing derivative of prednisolone developed for the treatment of inflammatory bowel disease (IBD) by NicOx SA.
Investigational
Matched Description: … NCX 1015 is nitric oxide-releasing derivative of prednisolone developed for the treatment of inflammatory …
CHIR-124
CHIR-124 is a potent inhibitor of Chk1 that potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo.
Experimental
Matched Description: … CHIR-124 is a potent inhibitor of Chk1 that potentiates the cytotoxicity of topoisomerase I poisons in …
Ifidancitinib
Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis).
Investigational
Matched Description: … for the Treatment of Atopic Dermatitis). ... Ifidancitinib is under investigation in clinical trial NCT03585296 (A Study of ATI-502 Topical Solution …
BMS-741672
BMS-741672 is under investigation in clinical trial NCT00699790 (Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance).
Investigational
Matched Description: … BMS-741672 is under investigation in clinical trial NCT00699790 (Proof of Confidence Study of CCR2 Antagonist …
Afimoxifene
Afimoxifene (4-Hydroxytamoxifen, trade name TamoGel) is a new estrogen inhibitor under investigation for a variety of estrogen-dependent conditions, including cyclic breast pain and gynecomastia. TamoGel is formulated using Enhanced Hydroalcoholic Gel (EHG) Technology. This technology enables percutaneous delivery of drugs that cannot be delivered orally. It is being developed by...
Investigational
Matched Description: … This technology enables percutaneous delivery of drugs that cannot be delivered orally. ... Hydroxytamoxifen, trade name TamoGel) is a new estrogen inhibitor under investigation for a variety of …
Anti-SARS-CoV-2 equine immunoglobulin fragments
Anti-SARS-CoV-2 equine immunoglobulin fragments, also known as INOSARS, is a polyvalent passive immunization being tested in the clinical trial NCT04514302 (Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19). INOSARS is composed of F(ab’)2 fragments extracted from hyperimmune equine serum.
Investigational
Matched Description: … [L27796] INOSARS is composed of F(ab’)2 fragments extracted from hyperimmune equine serum. ... polyvalent passive immunization being tested in the clinical trial NCT04514302 (Safety and Efficacy of …
VXA-CoV2-1
VXA-CoV2-1 is a non-replicating adenoviral vector-based oral tableted vaccine candidate that expresses a SARS-CoV-2 antigen and dsRNA adjuvant . This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell responses to both...
Investigational
Matched Description: … to the SARS-CoV-2 spike protein, induction of mucosal immune responses, and induction of T-cell responses ... to both vaccine antigens of the SARS-CoV-2 nucleocapsid and spike proteins[L30498]. ... This oral vaccine aims to induce immunogenicity through induction of potent serum neutralizing antibodies …
Resveratrol
Resveratrol (3,5,4'-trihydroxystilbene) is a polyphenolic phytoalexin. It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene synthase. It exists as cis-(Z) and trans-(E) isomers. The trans- form can undergo isomerisation to the cis- form when heated or exposed to ultraviolet...
Investigational
Matched Description: … In a 2004 issue of Science, Dr. ... It is a stilbenoid, a derivate of stilbene, and is produced in plants with the help of the enzyme stilbene ... Sinclair of Harvard University said resveratrol is not an easy molecule to protect from oxidation. …
LIC-477
LIC-477is indicated to be suitable for the treatment of psychosomatic disturbances, epilepsy, trigeminal neuralgia and cerebral spasticity.
Investigational
Matched Description: … LIC-477is indicated to be suitable for the treatment of psychosomatic disturbances, epilepsy, trigeminal …
EP0057
EP0057 is a conjugate of Insert's proprietary drug delivery molecule, Cyclosert, and the potent anti-cancer compound camptothecin.
Investigational
Matched Description: … EP0057 is a conjugate of Insert's proprietary drug delivery molecule, Cyclosert, and the potent anti-cancer …
Atamestane
Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.
Investigational
Matched Description: … Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms …
Tecemotide
Tecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell Lung.
Investigational
Matched Description: … Tecemotide has been used in trials studying the treatment of Prostate Cancer and Carcinoma, Non-Small-Cell …
GSK2245035
GSK2245035 is under investigation in clinical trial NCT02833974 (Effect of the GSK2245035 on the Allergen-induced Asthmatic Response).
Investigational
Matched Description: … GSK2245035 is under investigation in clinical trial NCT02833974 (Effect of the GSK2245035 on the Allergen-induced …
Vicagrel
Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel).
Investigational
Matched Description: … Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of …
DengueCide
DengueCide is a nonjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based polymer
Investigational
Matched Description: … DengueCide is a nonjugate of a dengue virus specific small chemical ligand and an amphiphilic PEG based …
Edecesertib
Edecesertib is under investigation in clinical trial NCT05629208 (Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)).
Investigational
Matched Description: … Edecesertib is under investigation in clinical trial NCT05629208 (Study of Edecesertib in Participants …
Pimicotinib
Pimicotinib is under investigation in clinical trial NCT05804045 (Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)).
Investigational
Matched Description: … Pimicotinib is under investigation in clinical trial NCT05804045 (Study of Pimicotinib (ABSK021) for …
Nelmastobart
Nelmastobart is under investigation in clinical trial NCT05990543 (Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer).
Investigational
Matched Description: … Nelmastobart is under investigation in clinical trial NCT05990543 (Combination of Nelmastobart and Capecitabine …
Supinoxin
Supinoxin is under investigation in clinical trial NCT02003092 (RX-5902 Treatment of Subjects With Triple Negative Breast Cancer).
Investigational
Matched Description: … Supinoxin is under investigation in clinical trial NCT02003092 (RX-5902 Treatment of Subjects With Triple …
L-377202
L-377202 is under investigation in clinical trial NCT00987753 (Study Evaluating the Safety and Tolerability of L-377202).
Investigational
Matched Description: … is under investigation in clinical trial NCT00987753 (Study Evaluating the Safety and Tolerability of …
TH0318
TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.
Investigational
Matched Description: … treatment of type 2 diabetes. ... TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the …
SPP1148
SPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.
Investigational
Matched Description: … SPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension …
Obexelimab
Obexelimab is under investigation in clinical trial NCT02725515 (A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus).
Investigational
Matched Description: … Obexelimab is under investigation in clinical trial NCT02725515 (A Study of the Effect of XmAb®5871 in …
Etamicastat
Etamicastat is under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453).
Investigational
Matched Description: … Six Multiple Rising Dose Regimens of BIA 5-453). ... under investigation in clinical trial NCT02840565 (Tolerability, Pharmacokinetics and Pharmacodynamics of …
Valomaciclovir stearate
Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster).
Investigational
Matched Description: … -348 for the Treatment of Herpes Zoster). ... Valomaciclovir stearate is under investigation in clinical trial NCT00831103 (A Phase 2b Trial of EPB …
Displaying drugs 10926 - 10950 of 12697 in total